SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,922,526 | -37.5% | 428,333 | -41.0% | 0.16% | -44.1% |
| Q2 2023 | $83,117,127 | -1.0% | 725,787 | +19.1% | 0.29% | -3.4% |
| Q1 2023 | $83,958,869 | +88351.3% | 609,148 | -16.8% | 0.30% | -12.9% |
| Q4 2022 | $94,921 | -99.9% | 732,532 | -35.1% | 0.34% | -28.6% |
| Q3 2022 | $124,801,000 | +275.7% | 1,129,016 | +154.8% | 0.48% | +289.4% |
| Q2 2022 | $33,220,000 | -22.8% | 443,171 | -19.6% | 0.12% | +2.5% |
| Q1 2022 | $43,046,000 | +118.8% | 551,020 | +152.2% | 0.12% | +110.5% |
| Q4 2021 | $19,677,000 | +5427.2% | 218,517 | +5571.3% | 0.06% | +5600.0% |
| Q3 2021 | $356,000 | -96.2% | 3,853 | -94.2% | 0.00% | -98.1% |
| Q3 2020 | $9,351,000 | +987.3% | 66,590 | +899.4% | 0.05% | +940.0% |
| Q4 2019 | $860,000 | -49.2% | 6,663 | -57.1% | 0.01% | -73.7% |
| Q4 2018 | $1,694,000 | – | 15,522 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |